A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2017
Price : $35 *
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders; Knee injuries
- Focus Adverse reactions; Therapeutic Use
- Sponsors Histogenics Corporation
- 11 Jan 2017 MRI data through 60 months follow up from this and a phase I trial of NeoCart published online in the American Journal of Sports Medicine.
- 10 Mar 2016 According to a Histogenics Corporation media release, the company expects to publish five-year data and MRI data from this trial in 2016.
- 22 Apr 2014 New trial record